Formulations of bendamustine | Patent Number 09572796

US 09572796 B2
Application Number15013424
Publication NumberUS 20160143887 A1
Pendency1 year, 20 days
Filled DateFeb 2, 2016
Priority DateJan 28, 2010
Publication DateMay 26, 2016
Expiration DateJan 27, 2030
Inventor/ApplicantsPhilip Christopher Buxton
Nagesh R. Palepu
ExaminesARNOLD, ERNST V
Art Unit1613
Technology Center1600
Assignments
Jpmorgan Chase Bank
Current
Eagle Pharmaceuticals Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.